Medicare Enrolled

Dr. James Bower, MD

Cardiovascular Disease · Miramar Beach, FL
Practice pattern: Cardiac & Cardiac— Practice combining cardiac and cardiac services
Speaking/Promotional
7720 US HIGHWAY 98 W STE 110, Miramar Beach, FL 32550
8502671603
In practice since 2006 (19 years)
NPI: 1588671440 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bower from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bower? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bower

Dr. James Bower is a cardiovascular disease in Miramar Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bower performed 1,829 Medicare services across 1,566 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bower received a total of $13,291 from 24 pharmaceutical and/or device companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bower is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 1,829 Medicare services$ $13,291 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,829
Medicare services
Bottom 42% in FL for cardiovascular disease
1,566
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Echocardiogram, transthoracic332$114$655
Office visit, established patient (30-39 min)232$87$310
Hospital follow-up visit, high complexity130$91$346
Office visit, established patient, complex (40-54 min)118$135$437
Regadenoson injection (Lexiscan) for heart stress test96$43$214
Prothrombin time test (blood clotting)80$4$17
Injection, perflutren lipid microspheres, per ml80$34$249
EKG interpretation and report69$6$30
Heart muscle strain imaging65$28$156
Electrocardiogram (EKG), 12-lead63$11$93
3d radiographic procedure61$18$380
Initial hospital admission, high complexity55$128$661
New patient office visit, complex (60-74 min)44$169$535
New patient office visit (45-59 min)39$117$404
Office visit, established patient (20-29 min)34$58$220
Technetium tc-99m tetrofosmin, diagnostic, per study dose34$91$415
Programming of dual lead pacemaker system32$29$148
Nuclear medicine studies of heart muscle at rest and with stress and spect27$284$1,364
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional26$16$68
Hospital follow-up visit, moderate complexity26$62$241
Ultrasound of heart, follow-up25$47$282
Ultrasound of heart with color-depicted blood flow, rate and valve function25$13$286
Ultrasound of heart during rest, exercise and/or drug-induced stress with report23$65$407
Ultrasound of heart blood flow, valves and chambers, follow-up22$11$94
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician21$16$77
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician21$10$51
Exercise or drug-induced heart stress test with electrocardiogram (ecg)18$20$230
Initial hospital admission, moderate complexity18$95$477
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician13$45$375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.5% high complexity
21.3% medium
56.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,291
Total received (2018-2024)
Avg $1,899/year across 7 years
Top 19% in FL for cardiovascular disease
24
Companies
222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,451 (63.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,270 (32.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$570 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$163
2023
$666
2022
$1,561
2021
$806
2020
$3,360
2019
$5,531
2018
$1,204

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$8,705
Novartis Pharmaceuticals Corporation
$849
BOSTON SCIENTIFIC CORPORATION
$583
UCB SA
$570
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$523
Boehringer Ingelheim Pharmaceuticals, Inc.
$422
E.R. Squibb & Sons, L.L.C.
$331
Janssen Pharmaceuticals, Inc
$243
Abbott Laboratories
$195
AstraZeneca Pharmaceuticals LP
$173
BIOTRONIK INC.
$119
Amgen Inc.
$90
Kestra Medical Technology Services, Inc.
$86
Otsuka America Pharmaceutical, Inc.
$66
Maquet Cardiovascular U.S. Sales, L.L.C.
$52
ARBOR PHARMACEUTICALS, INC.
$52
SCPHARMACEUTICALS INC.
$43
Novo Nordisk Inc
$41
PFIZER INC.
$34
Kiniksa Pharmaceuticals International, plc
$27
Regeneron Healthcare Solutions, Inc.
$26
Gilead Sciences, Inc.
$25
Kiniksa Pharmaceuticals, Ltd.
$22
Esperion Therapeutics, Inc.
$13
Top 3 companies account for 76.3% of total payments
Associated products mentioned in payments ›
Arcalyst · Assure WCD · BRILINTA · Bidil · CARDIOHELP · Corlanor · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FUROSCIX · JARDIANCE · LEQVIO · LifeVest · MITRACLIP · Mitra Clip system · MitraClip System · NEXLETOL · Ozempic · PERCLOSE PROGLIDE · PRADAXA · PRALUENT ALIROCUMAB INJECTION · SAMSCA · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $727 per 100 Medicare services performed
Looking for a cardiovascular disease in Miramar Beach?
Compare cardiovascular diseases in the Miramar Beach area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
12
Per 100K population
15.0
County median income
$79,281
Nearest hospital
SACRED HEART HOSPITAL ON THE EMERALD COAST
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bower is a cardiac & cardiac specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 19%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bower experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Bower performed 332 echocardiogram, transthoracic services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bower receive payments from pharmaceutical companies?
Yes. Dr. Bower received a total of $13,291 from 24 companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bower's costs compare to other cardiovascular diseases in Miramar Beach?
Dr. Bower's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bower) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →